A new report urges equitable development and oversight of AI in neurological imaging to avoid worsening healthcare disparities.
Key Details
- 1UCLA Health and collaborators published a Neurology journal report assessing AI's dual impact in neurological care.
- 2AI already aids doctors in classifying brain tumors and stroke imaging for faster decisions.
- 3Researchers highlight risks for bias due to underrepresentation of certain groups in datasets.
- 4Three guiding principles recommended: diverse stakeholder input, AI education for neurologists, and strong independent governance.
- 5The aim is for AI to advance equity, particularly in resource-limited and underrepresented communities.
- 6The literature review involves experts from healthcare, FDA, and AI industry.
Why It Matters
As AI tools become deeply integrated in radiology and neurology, the risk of amplifying health disparities looms if bias and poor governance are not addressed. Adopting proposed safeguards is essential to ensure equitable benefits for all patients and sustainable trust in imaging AI.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.